DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 100,000 Value ($000) $1,651 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 100,000 Value ($000) $1,452 Avg Close $14.37 Range $12.58 - $16.20
Q2 2025
Shares 100,000 Value ($000) $1,399 Avg Close $14.07 Range $10.57 - $16.97
Q1 2025
Shares 100,000 Value ($000) $1,360 Avg Close $19.16 Range $13.30 - $24.34